I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Evaluation of Efficacy and Safety of Belantamab Mafodotin Bortezomib and Dexamethasone Versus Daratumumab Bortezomib and Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
This is a Phase 3, randomized, open-label study designed to evaluate safety and efficacy of belantamab mafodotin in combination with bortezomib/dexamethasone (Arm A) versus daratumumab in combination with bortezomib/dexamethasone (Arm B) in the participants with relapsed recurrent multiple myeloma.
refractory multiple myeloma
daratumumab
belantamab mafodotin
recurrent multiple myeloma
bortezomib/dexamethasone
- 0 views
- 19 Feb, 2024